Skip to main content
K

KIM FOREST ENTERPRISE CO., LTD. — Investor Relations & Filings

Ticker · 6645 TW Professional, scientific and technical activities
Open in API
Filings indexed 22 across all filing types
Latest filing 2026-04-20 Regulatory Filings
Country TW Taiwan
Listing TW 6645

About KIM FOREST ENTERPRISE CO., LTD.

https://www.kimforest.com

Kim Forest Enterprise Co., Ltd. specializes in precision medicine and molecular diagnostics, providing integrated solutions for clinical research and healthcare. The company offers a "One Stop Solution" encompassing experimental consultation, laboratory equipment supply, and bioinformatics analysis. Key products and services include Next-Generation Sequencing (NGS), PCR systems, ELISA readers, and high-content imaging systems. The company focuses on genetic testing for cancer screening, hereditary diseases, and personalized health management. By synthesizing genomic data with clinical insights, Kim Forest facilitates biomarker identification and the development of optimized treatment strategies. Its portfolio also extends to customized enzymes, drug screening technologies, and precision nutrition, supporting the advancement of personalized medicine through comprehensive technical expertise and reliable diagnostic reporting.

Recent filings

Filing Released Lang Actions
114年年報及股東會資料 — 2026_6645_20260522FE2.pdf
Regulatory Filings
2026-04-20 Chinese
公告本公司初次申請股票創新板上市時所出具之承諾事項暨 其後續執行情形
Regulatory Filings Classification · 1% confidence The document is a regulatory disclosure on the Taiwan Stock Exchange’s public information observatory detailing the company’s listing commitments for its first application to the innovation board and subsequent execution status. It is neither an AGM presentation, financial report, earnings release, board change, nor any other specialized category. It does not merely announce publication of a report but provides substantive regulatory commitments and compliance details. This fits the fallback category “Regulatory Filings” (RNS).
2026-04-10 Chinese
115年3月背書保證與資金貸與
Regulatory Filings Classification · 1% confidence The document is a standardized disclosure of the company’s funding loans and endorsement/guarantee balances for the current month, with all amounts at zero. It is a routine regulatory announcement filed to the market observation post system (MOPS) under Taiwanese rules. It does not constitute an annual or interim report, capital fundraising notice, board change, or dividend, but rather a general regulatory filing of guarantee/loan information. Therefore, it falls under the fallback category “Regulatory Filings” (RNS).
2026-04-10 Chinese
115年3月營業收入
Regulatory Filings Classification · 0% confidence The provided text is an error page notice indicating that the requested page cannot be accessed, with no substantive corporate filing content or reference to any report type. It does not match any specific filing category definitions (e.g., Annual Report, Earnings Release, Proxy Materials). As a nonstandard, miscellaneous notice, it falls under the fallback category for general regulatory or miscellaneous announcements: RNS (Regulatory Filings).
2026-04-10 Chinese
公告本公司修訂「國內第一次有擔保轉換公司債發行及 轉換辦法」之債權人異議期間屆滿
Capital/Financing Update Classification · 1% confidence The document is a brief corporate announcement on the Taiwan Public Information Observatory regarding the expiration of the creditor objection period for a secured convertible bond issuance and the next steps for regulatory approval. It is not a full financial or interim report, nor a dividend/proxy/AGM notice. It relates directly to the company’s financing and capital structure (convertible bond issuance). Therefore it falls under Capital/Financing Update (CAP).
2026-04-08 Chinese
115年03月內部人持股異動(事後)
Director's Dealing Classification · 1% confidence The document is a detailed listing of shareholdings and changes in share counts for company insiders (directors, chairperson, general manager, spouses, minors, etc.). It is a regulatory disclosure of personal share transactions/holdings by company directors and executives, fitting the description of a Director’s Dealing report.
2026-04-07 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.